Health Care/Hospital

Juniper Therapeutics Acquires Exclusive Rights for SAR Registration for Anti-Viral COVID-19 Drug from Ping An-Shionogi Hong Kong for Singapore

First drug to show both clinical symptomatic efficacy for five typical Omicron-related symptoms and antiviral efficacy SINGAPORE, Dec. 22, 2023 /PRNewswire/ -- Singapore-headquartered Juniper Therapeutix , a science-led healthcare company focused on commerciali...

2023-12-22 07:00 2249

Jung Kwan Jang to Boost the Popularity of Red Ginseng by Employing various forms, from Film to Jelly

SEOUL, South Korea, Dec. 22, 2023 /PRNewswire/ -- Holding the top spot in global ginseng retail for a decade, Jung Kwan Jang declared to boost the popularity of red ginseng by employing various forms, from film to jelly. Red ginseng, which is a steamed and dried ginseng, has been traditionally c...

2023-12-22 07:00 2167

International Clinical Trial Results Released! Responding to the Virus Resurgence, Lianhua Qingwen Capsules Provide New Evidence

SINGAPORE, Dec. 21, 2023 /PRNewswire/ -- Recently, according to multiple reports from local Singaporean media, confirmed cases of COVID-19 are steadily increasing, with the average number of daily hospitalizations on the rise. The virus, once vigorously fought against, seems to be making a comeba...

2023-12-21 18:06 2120

CStone sells to Servier its exclusive rights to TIBSOVO® in Greater China and Singapore

* The deal enables CStone to prioritize its resources to focus on the development of first-in-class and best-in-class therapies with global rights. * The deal enables Servier to potentially bring additional indications and accessibility of TIBSOVO® to patients in Greater China (including main...

2023-12-21 17:10 1894

Everest Medicines' Partner Calliditas Therapeutics Announces Nefecon® the Only FDA-approved Treatment for IgA Nephropathy to Significantly Slow Kidney Function Decline

SHANGHAI, Dec. 21, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company")'s licensing partner Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas") announced that the U.S. Food and Drug Administration (FDA) had approved Nefecon® delayed rele...

2023-12-21 10:30 6640

EVERISE ANNOUNCES SUCCESSFUL CLOSURE OF INVESTMENT BY WARBURG PINCUS, JOINING BROOKFIELD FOR THE NEXT PHASE OF GROWTH

NEW YORK, SINGAPORE and MUMBAI, Dec. 21, 2023 /PRNewswire/ -- Everise, a leading global healthcare services outsourcing company, announced today the successful completion of the company's previously announced investment from Warburg Pincus. Warburg Pincus joins existing investorBrookfield, valuin...

2023-12-21 10:16 4444

ENA Building Momentum Globally in Support of Emergency Nurses

Partnerships help gold standard TNCC and ENPC courses reach more international ED nurses SCHAUMBURG, Ill., Dec. 21, 2023 /PRNewswire/ -- After a year dedicated to expanding its international connections, theEmergency Nurses Association stands poised to reach more emergency nurses globally with k...

2023-12-21 09:00 1627

EpiVax Licenses ISPRI Toolkit to Eisai for Preclinical in silico Immunogenicity Screening

PROVIDENCE, R.I., Dec. 21, 2023 /PRNewswire/ -- EpiVax, Inc. ("EpiVax"), an internationally recognized leader in the field of immunogenicity, today announced that Eisai Co. Ltd. ("Eisai") has licensed EpiVax's ISPRI toolkit for preclinical immunogenicity risk assessment of Eisai's robust biologic...

2023-12-20 23:45 1585

Dx&Vx co-develops a bio-healthcare big data platform with LG CNS

- Possessing human genome and microbiome data in all clinical stages - Becoming a global bio-healthcare big data platform company SEOUL, South Korea, Dec. 20, 2023 /PRNewswire/ -- Dx&Vx will develop a bio-healthcare big data platform utilizing AI technology provided by LG CNS. Dx&Vx recently anno...

2023-12-20 22:00 1912

Fapon Shines at JITMM 2023

DONGGUAN, China, Dec. 20, 2023 /PRNewswire/ -- Fapon, a global leading life sciences company, showcased its expertise at the Joint International Tropical Medicine Meeting (JITMM) 2023, the leading tropical-medicine conference in Southeast Asia held in Bangkok, Thailand, from December 12th to 15th....

2023-12-20 17:39 1949

INNOTIER TEAMED UP WITH TERESA MO & JENNIFER YU TO LAUNCH A NEW FASHIONABLE COLLECTION FOR EPIDEMIC PREVENTION

HONG KONG, Dec. 20, 2023 /PRNewswire/ -- This winter is the first winter in Hong Kong after the lifting of the mask mandate. The Department of Health expects a high chance of outbreaks of upper respiratory tract diseases, mainly seasonal influenza.Hong Kong has already experienced a summer flu ou...

2023-12-20 10:00 1812

International Collaboration to Improve Cancer Care in Sub-Saharan Africa Updates Resources for Sixth Year

Collective effort to optimize and standardize treatment practices now covers more than 90% of adult cancer incidences plus an increasing number of pediatric diseases. PLYMOUTH MEETING, Pa., Dec. 20, 2023 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading ac...

2023-12-20 09:06 1463

Lynk Pharmaceuticals Announced First Rheumatoid Arthritis Patient Dosed in Phase Ⅲ Clinical Study of LNK01001

BOSTON and HANGZHOU and SHANGHAI, China, Dec. 20, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced that it has dosed the first patient with Rheumatoid Arthritis (RA) in a Phase Ⅲ clinical trial...

2023-12-20 08:00 2114

ShiraTronics Announces Landmark Achievement: World's First Implant of its Innovative Chronic Migraine System

MINNEAPOLIS, Dec. 20, 2023 /PRNewswire/ -- ShiraTronics, Inc., a trailblazing clinical-stage medical device company, today announced a landmark achievement with the successful implantation of its Chronic Migraine System in the world's first six patients. This remarkable milestone represents a sig...

2023-12-19 23:12 1585

Parexel Recognized with Frost & Sullivan's 2023 North American Customer Value Leadership Award for Impactful Real-world Evidence Solutions Addressing Customer Needs

Informing clinical development, enhancing the patient experience, mitigating risk and meeting health authority requirements across the product lifecycle are the foundation of Parexel's Real-world Evidence solutions SAN ANTONIO, Texas, Dec. 19, 2023 /PRNewswire/ -- Frost & Sullivan today recogniz...

2023-12-19 22:00 1385

Burjeel Holdings Oncology Conference Marks 10 Years, Focusing on Equitable Solutions for Cancer Care

Experts stress collaboration and innovation are key to progress WASHINGTON, Dec. 19, 2023 /PRNewswire/ -- The 10th anniversary of the Burjeel Holdings Oncology Conference, held in partnership with Foreign Policy, brought together leading global experts to tackle the complex challenges of cancer ...

2023-12-19 20:20 1856

LTS receives $4.3 Million grant for the development of contraceptive Microneedle Array Patches

ANDERNACH, Germany, Dec. 19, 2023 /PRNewswire/ -- LTS, a leading pharmaceutical technology company, announced today that it has received a grant from the Bill & Melinda Gates Foundation. The purpose of the grant is to support the development of microneedle array patches (MAP) for self-administrat...

2023-12-19 20:00 1259

Cutting-Edge Gut Microbiome Research: NOSTER's latest solutions for comprehensive gut bacteria-based metabolite and microbiota analysis

KYOTO, Japan, Dec. 19, 2023 /PRNewswire/ -- Japan's Noster Inc., a premier provider of gut microbiome analysis services, is proud to unveil groundbreaking updates in its research on cutting-edge gut bacteria-based metabolite and gut microbiota analysis services. These advancements have far-reachi...

2023-12-19 19:22 1386

Paving the Way Towards a More Sustainable Future - Fullerton Health Accelerates Regional Growth with Sustainability Framework

SINGAPORE, Dec. 19, 2023 /PRNewswire/ -- Fullerton Health Group (FHG) continues to make important strides toward integrating its sustainability goals within its operations and ecosystem. The release of its FY2022 Sustainability Report underscores the Group's commitments and progress in achieving ...

2023-12-19 16:13 1487

Clarivate Reveals Stronger Outlook for Pulsed-field Ablation Market and Potential for Device to Revolutionize Treatment Paradigm

MedTech Insights report series analyzes the impact of recent breakthroughs in pulsed-field ablation, signaling its promising future in the electrophysiology mapping and ablation device market LONDON, Dec. 19, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people an...

2023-12-19 15:00 1265
1 ... 33343536373839 ... 554